Hims & Hers Health stock tests $34.44 resistance amid buyer support

Traders Union
All News
Stocks
Hims & Hers Health gains 2.48% today

Highlights

Shares of Hims & Hers Health fell to $25.00 as Kaplan Fox & Kilsheimer LLP initiated an investigation into potential securities law violations.
The legal probe has introduced increased scrutiny and risk of volatility, though market interest in the stock remains evident.
Technical analysis shows bullish momentum with strong buy signals, forecasting a price range of $29.28 to $34.44 over the next few sessions.

Legal probe intensifies volatility as sentiment rebounds from selloff

Hims & Hers Health is under investigation by Kaplan Fox & Kilsheimer LLP for potential securities law violations following a sharp drop in share price to $25.00, as reported by Theglobeandmail. The probe brings additional legal scrutiny and raises the perceived risk around the stock, which can lead to heightened volatility and shifts in investor behavior. Although the investigation creates a challenging backdrop, underlying market sentiment appears to have rebounded, with interest in the stock remaining evident despite recent legal developments.

Bullish momentum holds above key supports amid mixed signals

On the technical front, HIMS trades above the MA-20 at $30.11, MA-50 at $29.45, and the MA-200 at $28.94. The Ichimoku Kijun level at $30.27 provides immediate support on the daily chart. Momentum remains strong with both the MACD and ADX maintaining a buy bias, while the RSI registers a reading of 67.36, also on buy. In contrast, Stoch RSI signals a strong sell, though CCI is supportive with a buy reading. Bull/Bear Power is well into overbought territory, reflecting prevailing buyer strength, while the Awesome Oscillator is currently neutral, showing no clear reinforcement of the ongoing trend.

Sideways consolidation expected as bullish bias outweighs downside risk

In the near term, the price is anticipated to fluctuate within a $29.28 to $34.44 range over the next several sessions, reflecting the asset's typical volatility. The baseline scenario for HIMS points to a sideways consolidation pattern within these bounds, with a 73% probability assigned to an upward move. Should resistance be overcome, the bullish case could unfold, while a break below support would indicate downside risk with a lower 27% probability.

Viktoras Karapetjanc, Traders Union expert, sees Hims & Hers Health as maintaining strong price action above key technical levels despite the backdrop of legal investigations. He believes the market is showing resilience and that bullish momentum remains intact, supported by positive sentiment and buyer dominance. The ongoing legal probe introduces some risk, but recent gains suggest confidence has not been shaken. "For now, positive sentiment and technical strength outweigh legal headwinds — as long as price stays above immediate support, I remain constructive on HIMS."

Earlier, analysts noted that Hims & Hers Health showed strong technical momentum, supported by sustained growth in its international business. The current environment introduces heightened legal risk and volatility, and traders should monitor price action within the $29.28 to $34.44 range for potential breakouts or breakdowns in the sessions ahead.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.